Depression studies

Prefrontal circuits for cognitive flexibility in an extradimensional set-shifting task for humans.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria

Sponsor

Department of Psychiatry and Psychotherapy, Medical University of Vienna

A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensiv...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

France, Belgium, Bulgaria, + 4 others

Sponsor

Janssen-Cilag International NV

Xenon als Antidepressivum

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Klinik für Anästhesiologie Universitätsklinikum Aachen

A double-blind, placebo-controlled, randomized dose-ranging trial to investigate efficacy and safety of intravenous MIJ821 infusion in addition to comprehensive standard of care on the rapid reduct...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany, Netherlands, Poland, + 1 other

Sponsor

Novartis Pharma AG

Interventional, randomised, double-blind, parallel-group study of the efficacy and safety of initial administration of 17 mg vortioxetine intravenously with 10 mg/day vortioxetine orally in patient...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Estonia, Finland, Lithuania, + 1 other

Sponsor

H. Lundbeck A/S

Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose long-term study to evaluate the maintenance of efficacy and safety of 1 to 3 mg/day of brexpiprazole a...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom, Bulgaria, Estonia, + 6 others

Sponsor

H. Lundbeck A/S

Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 12 to 17 years, with Major depressive disor...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, United Kingdom, Belgium, + 9 others

Sponsor

H. Lundbeck A/S

The cognition game study

This study isn't currently recruiting.

Countries

Netherlands

Sponsor

MyCognition

A Personalized Approach to Effects of Affective Bias Modification on Symptom Change and Rumination

This study has finished and is no longer accepting participants.

Countries

Norway

Sponsor

University of Oslo

Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

This study has finished and is no longer accepting participants.

Countries

China

Sponsor

Vigonvita Life Sciences

Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

This study has finished and is no longer accepting participants.

Countries

United States

Sponsor

Supernus Pharmaceuticals, Inc. (Pharmaceutical company)

Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder

This study was withdrawn before enrollment.

Countries

United States

Sponsor

Stanford University